Has Annunziato Amendola, MD received payments from drug or device companies?

Yes. Drug and device makers reported $981,843 in general payments to Annunziato Amendola, MD across 234 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Annunziato Amendola, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Annunziato Amendola, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Annunziato Amendola, MD

Sports Medicine · Iowa City, IANPI 1043202419

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $772,829 of the $981,843 with a category attached, or 78.7%. Arthrex accounts for 85.0% of it on its own, with 17 other manufacturers making up the rest. Among sports medicine clinicians in IA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$981,843in general payments, 2019–2025

Across 234 payments — averaging $4195.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Arthrex$835K
Anika Therapeutics, Inc.$72K
Limacorporate S.p.a.$52K
Lima USA, Inc.$12K
Bioventus LLC$5K
Tricoast Surgical Solutions LLC$3K
plus $4K from 12 others

$224,826in research payments, 2019–2025

Across 12 payments — averaging $18,735 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Bioventus LLC$148K
Stryker$77K
Arthrex$67

What the payments were for

Royalty or licence$772,82979%
Consulting fees$84,3979%
Speaking & faculty fees$21,8952%
Travel & lodging$21,6552%
Food & beverage$4,2750%
Education$5,0791%
Ownership interest$58,2636%
Other$13,4501%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Arthrex	171	$834,569
Anika Therapeutics, Inc.	4	$71,712
Limacorporate S.p.a.	20	$51,943
Lima USA, Inc.	11	$12,276
Bioventus LLC	2	$4,550
Tricoast Surgical Solutions LLC	9	$2,738
Southtech Orthopedics	4	$2,679
Nextremity Solutions Inc.	1	$311
DJO, LLC	1	$250
Exactech, Inc.	2	$208
Heron Therapeutics, Inc.	1	$121
Linvatec Corporation	1	$115
Miach Orthopaedics, Inc.	1	$97
Paragon 28, Inc.	1	$89
Vericel Corporation	2	$59
Abanza Inc.	1	$54
Next Science LLC	1	$52
Medtronic	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ARTHREX$2,854,805
DISTAL EXTREMITIES INSTRUMENTS OTHER INSTRUMENTS ENDOSCOPIC STR$148,457
ARTHROPLASTY IMPLANTS OSTEOTOMY IBALANCE HTO$148,457
ARTHROPLASTY IMPLANTS KNEE ARTHROPLASTY PATELLO FEMORAL$88,535
ARTHROPLASTY IMPLANTS OSTEOTOMY HTO PLATES$83,803
ARTHROPLASTY IMPLANTS OSTEOTOMY OSTEOTOMY SCREWS$83,803
ARTHROPLASTY IMPLANTS OSTEOTOMY DFO PLATES$65,654
ARTHROPLASTY IMPLANTS KNEE ARTHROPLASTY TOTAL KNEE$64,654
ARTHROPLASTY IMPLANTS KNEE & HIP ARTHROPLASTY PATELLO FEMORAL$59,922
Product Portfolio$57,439
DISTAL EXTREMITIES INSTRUMENTS SOFT TISSUE ENDOSCOPIC STR$35,498
KNEE & HIP IMPLANTS OSTEOTOMY IBALANCE HTO$35,498
ARTHROPLASTY IMPLANTS TOTAL KNEE ARTHROPLASTY TOTAL KNEE$35,498
ARTHROPLASTY IMPLANTS PARTIAL KNEE ARTHROPLASTY PATELLO FEMORAL$35,498
DISTAL EXTREMITIES INSTRUMENTS FOOT & ANKLE HINDFOOT & ANKLE$24,097
KNEE & HIP IMPLANTS OSTEOTOMY DFO PLATES$11,401
DISTAL EXTREMITIES INSTRUMENTS DEVICE SPECIFIC INSTRUMENTS HINDFOOT & ANKLE$500
VANTAGE$208
Zynrelef$121
BioBrace 23mm$115

How this compares

$981,843 in reported general payments places this provider in the 95th percentile of 33 sports medicine providers in Iowa.

See all sports medicine providers in Iowa →

Medicare billing

Part B allowed, 2024

$30,963

Medicare patients

Services billed

170

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other sports medicine in Iowa City

Brian WolfIowa City$298K
Mederic HallIowa City$26K
Matthew BollierIowa City$22K
Bruno VaroneIowa City$13K
Keith WolstenholmeIowa City$5K
Michael KrillIowa City$3K
Ashlee EnzingerIowa City$1K
Timothy ThomsenIowa City$818
Matthew NegaardIowa City$201
Blake BodendorferCouncil Bluffs$95K

See the full list for Iowa →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →